Destination Known: Targeted Drug Delivery in Atherosclerosis and Thrombosis
about
Targeting and therapeutic peptides in nanomedicine for atherosclerosis.Leach-proof magnetic thrombolytic nanoparticles and coatings of enhanced activityEncapsulation of eptifibatide in RGD-modified nanoliposomes improves platelet aggregation inhibitory activity.Multifunctional Thrombin-Activatable Polymer Capsules for Specific Targeting to Activated Platelets.Magnetically controlled release of recombinant tissue plasminogen activator from chitosan nanocomposites for targeted thrombolysis
P2860
Destination Known: Targeted Drug Delivery in Atherosclerosis and Thrombosis
description
im Oktober 2013 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2013
@uk
name
Destination Known: Targeted Drug Delivery in Atherosclerosis and Thrombosis
@en
Destination Known: Targeted Drug Delivery in Atherosclerosis and Thrombosis
@nl
type
label
Destination Known: Targeted Drug Delivery in Atherosclerosis and Thrombosis
@en
Destination Known: Targeted Drug Delivery in Atherosclerosis and Thrombosis
@nl
prefLabel
Destination Known: Targeted Drug Delivery in Atherosclerosis and Thrombosis
@en
Destination Known: Targeted Drug Delivery in Atherosclerosis and Thrombosis
@nl
P2093
P2860
P921
P356
P1476
Destination Known: Targeted Drug Delivery in Atherosclerosis and Thrombosis
@en
P2093
Christoph E. Hagemeyer
Erik Westein
Ulrike Flierl
P2860
P304
P356
10.1002/DDR.21103
P577
2013-10-21T00:00:00Z